Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth
The Analyst Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE:IWIN) (OTC:IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 "on a
Field Trip Health Launches Field Trip Online Therapy
Field Trip Health Updates Time for Q2 Earnings Results
Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV:FTHW) (the "Company" of "Field Trip"), a global leader in the delivery of psychedelic therapies, announced today that it
Field Trip Health Appoints Stacey Hoisak as VP, General Counsel
Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call
These Are The Top Companies And Most Influential People In The Psychedelics Space: Meet The Winners Of The Microdose Awards
Which are the top companies and who are the most influential people in the psychedelics space? According to Microdose Psychedelic Insights, host of the Microdose Awards, these are the ones to watch. T
Field Trip Health & Wellness Reports Q1 Results
Field Trip Health & Wellness press release (OTCPK:FTHWF): Q1 Revenue of C$1.82M (+109.2% Y/Y). Net loss for the clinics was C$8.2M
Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results
Completed corporate reorganization on August 11, 2022 separating the drug development ("Reunion Neuroscience Inc." or "Reunion") and healthcare and wellness ("Field Trip Health & Wellness" or "Fie
Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET
TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV:FTHW) (the "Company" or "Field Trip"), a global leader in psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first qua
Loading...
No Stock Yet